Company announcement no 2020-13

26 November 2020

Financial calendar 2021

 

22 January

Deadline for submission of items for the agenda of the annual
general meeting*

19 January to 8 February

 

Quiet period prior to publication of Annual Report 2020

9 February

 

Annual Report 2020

5 March

 

Annual general meeting

13 April to 3 May

 

Quiet period prior to publication of Interim Management Statement

4 May

 

Interim Management Statement

16 and 17 June

Capital Markets Days

 

22 July to 11 August

 

Quiet period prior to publication of Interim Report 2021

12 August

 

Interim Report 2021

12 October to 1 November

 

Quiet period prior to publication of Interim Management Statement

2 November

 

Interim Management Statement

 

*Please note that if a shareholder would like to have a specific item included in the agenda for the general meeting on 5 March 2021, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 22 January 2021.

 

Further information:

Mathias Holten Møller, Head of Investor Relations

Christian Lange, Investor Relations Officer

Phone +45 3917 7300

www.demant.com

 

 

Contacts

  • Mathias Holten Møller, Director, Head of Investor Relations, +45 3913 8827, msmo@demant.com
  • Christian Lange, Investor Relations Officer, +45 3917 7300, chln@demant.com

About Demant A/S

Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.

Attachments

  • Download announcement as PDF.pdf
  • 2020-13 Financial calendar 2021.pdf

© Ritzau Denmark, source Ritzau English Regulatory Releases